COVID-19-associated pulmonary aspergillosis (CAPA) is a recently described disease entity
affecting patients with severe pulmonary abnormalities treated in intensive care units …

Aspergillus co-infection in patients with severe coronavirus disease 2019 (COVID-19)
pneumonia, leading to acute respiratory distress syndrome, has recently been reported. To …

First reports of cases and case series of COVID-19-associated pulmonary aspergillosis
(CAPA) emerged during the first months of the pandemic. Prevalence rates varied widely …

Although invasive pulmonary aspergillosis (IPA) is typically described in
immunocompromised host, patient with severe influenzae can develop IPA. Similarly …

Invasive Pulmonary Aspergillosis (IPA) has been recognized as a possible secondary
infection complicating Coronavirus disease 2019 (COVID-19) and increasing mortality. The …

Background COVID‐19–associated pulmonary aspergillosis (CAPA) has emerged as an
invasive fungal disease, often affecting previously immunocompetent, mechanically …

Objectives Information on the recently COVID‐19‐associated pulmonary aspergillosis
(CAPA) entity is scarce. We describe eight CAPA patients, compare them to colonised ICU …

ABSTRACT COVID-19-associated pulmonary aspergillosis (CAPA) was recently reported as
a potential infective complication affecting critically ill patients with acute respiratory distress …

Pneumonia caused by severe acute respiratory syndrome coronavirus 2 emerged in China
at the end of 2019. Because of the severe immunomodulation and lymphocyte depletion …

Like severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory
distress syndrome (ARDS) has emerged as an important disease that predisposes patients …